99热在线只有精品,亚洲成人精品女人久久,91国在线啪精品一区

Trioxifene mesylate

NMR下載 COA and HPLC MSDS下載
names：
Ketone, 3,4-dihydro-2-(p-methoxyphenyl)-1-naphthyl-p-(2-(1-pyrrolidinyl)ethoxy)phenyl, methanesulfonate
CAS號：
68307-81-3
MDL Number：
MF(分子式)： C60H64N2O8S MW(分子量)： 973.24
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

貨品編碼	規(guī)格	純度	價格 (￥)	現(xiàn)價(￥)	特價(￥)	庫存描述	數(shù)量	總計 (￥)

大包裝詢價提供各種包裝，敬請垂詢
收藏商品商品點評加入購物車立即購買

快速詢價

收起

你想詢價的產(chǎn)品

*產(chǎn)品名稱：

CAS號：

產(chǎn)品編號：

需求描述：

請準(zhǔn)確填寫您的聯(lián)系方式，以便為您提供最好的服務(wù)。

*公司名稱：

*電子郵箱：

聯(lián)系人：

*電話：

*驗證碼：

詢價

中文別名	Ketone, 3,4-dihydro-2-(p-methoxyphenyl)-1-naphthyl-p-(2-(1-pyrrolidinyl)ethoxy)phenyl, methanesulfonate
英文別名	Trioxifene mesylate; LY133314; LY-133314; LY 133314;
CAS號	68307-81-3
Inchi	InChI=1S/C59H60N2O5.CH4O3S/c1-63-45-21-15-43(16-22-45)51-27-19-41-11-3-5-13-49(41)57(51)55-39-47(65-37-35-60-31-7-8-32-60)25-29-53(55)59(62)54-30-26-48(66-38-36-61-33-9-10-34-61)40-56(54)58-50-14-6-4-12-42(50)20-28-52(58)44-17-23-46(64-2)24-18-44;1-5(2,3)4/h3-6,11-18,21-26,29-30,39-40H,7-10,19-20,27-28,31-38H2,1-2H3;1H3,(H,2,3,4)
InchiKey	DHFAPIZDRMEMLX-UHFFFAOYSA-N
分子式 Formula	C60H64N2O8S
分子量 Molecular Weight	973.24
溶解度Solubility
性狀	Solid powder
儲藏條件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

產(chǎn)品說明	Trioxifene mesylate(CAS:68307-81-3):僅限應(yīng)用于工業(yè)或者科學(xué)研究過程中非醫(yī)療目的，不應(yīng)用于人類或動物的臨床診斷以及治過程療，該產(chǎn)品非藥用，非食用。
Introduction	Trioxifene mesylate is an antiestrogen that inhibits growth hormone secretion.
Application1
Application2
Application3

警示圖
危險性	Warning
危險性警示
安全聲明
安全防護(hù)
備注

[1]Lee RW, Buzdar AU, Blumenschein GR, Hortobagyi GN. Trioxifene mesylate in the treatment of advanced breast cancer. Cancer. 1986 Jan 1;57(1):40-3. PubMed PMID: 3940620.

[2]Arafah B, Manni A, Pearson OH. Trioxifene mesylate (LY 133314): a new antiestrogen which inhibits growth hormone secretion in the rat. Eur J Cancer. 1980;Suppl 1:281-5. PubMed PMID: 7032941.

[3] Witte RS, Pruitt B, Tormey DC, Moss S, Rose DP, Falkson G, Carbone PP, Ramirez G, Falkson H, Pretorius FJ. A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects. Cancer. 1986 Jan 1;57(1):34-9. PubMed PMID: 3079661.

[4] Neubauer BL, McNulty AM, Chedid M, Chen K, Goode RL, Johnson MA, Jones CD, Krishnan V, Lynch R, Osborne HE, Graff JR. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. Cancer Res. 2003 Sep 15;63(18):6056-62. PubMed PMID: 14522935.

[5] Black LJ, Jones CD, Goode RL. Differential interaction of antiestrogens with cytosol estrogen receptors. Mol Cell Endocrinol. 1981 Apr;22(1):95-103. PubMed PMID: 7239000.

6: Rose DP, Fischer AH, Jordan VC. Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas. Eur J Cancer Clin Oncol. 1981 Aug;17(8):893-8. PubMed PMID: 7198978.7: Black LJ, Goode RL. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice. Life Sci. 1980 Apr 28;26(17):1453-8. PubMed PMID: 7382727.8: Wakeling AE, Valcaccia B. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens. J Endocrinol. 1983 Dec;99(3):455-64. PubMed PMID: 6644236.9: Castracane VD, Kuehl TJ, Goldzieher JW. The effect of estrogen antagonism on progesterone production in early pregnancy in the baboon (Papio cynocephalus). Am J Obstet Gynecol. 1983 Mar 15;145(6):725-9. PubMed PMID: 6829661.10: Jones CD, Blaszczak LC, Goettel ME, Suarez T, Crowell TA, Mabry TE, Ruenitz PC, Srivatsan V. Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone. J Med Chem. 1992 Mar 6;35(5):931-8. PubMed PMID: 1548683.1

對不起，暫無產(chǎn)品評價！

MSDS

SDS 1.0 中文

展開

SDS 1.0 英文

展開